Table: Astellas -2024/25 parent results

Astellas Pharma

25/04/2025 07:30

Apr 25 (Reuters)- 
          Astellas Pharma Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            789.62          688.44                                
                 (+14.7 pct)     (+12.2 pct)                             
  Operating        267.31          193.98                                
                 (+37.8 pct)     (+48.5 pct)                             
  Recurring        431.12          373.26                                
                 (+15.5 pct)     (+10.4 pct)                             
  Net              319.72          292.16                                
                 (+9.4 pct)      (-7.0 pct)                              
  EPS            178.59 yen      162.92 yen                              
  EPS Diluted    178.55 yen      162.87 yen                              
  Ann Div         74.00 yen       70.00 yen      78.00 yen               
  -Q2 Div         37.00 yen       35.00 yen      39.00 yen               
  -Q4 Div         37.00 yen       35.00 yen      39.00 yen               
  
  NOTE - Astellas Pharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4503.T